Analysts expect CIGNA Co. (NYSE:CI) to report earnings per share of $3.39 for the current fiscal quarter, according to Zacks Investment Research. Six analysts have provided estimates for CIGNA’s earnings, with estimates ranging from $3.20 to $3.54. CIGNA reported earnings per share of $2.77 during the same quarter last year, which would suggest a positive year over year growth rate of 22.4%. The company is expected to report its next earnings results on Friday, May 4th.
On average, analysts expect that CIGNA will report full-year earnings of $12.81 per share for the current financial year, with EPS estimates ranging from $11.65 to $13.21. For the next year, analysts expect that the company will post earnings of $14.46 per share, with EPS estimates ranging from $13.96 to $15.10. Zacks’ earnings per share averages are an average based on a survey of sell-side analysts that that provide coverage for CIGNA.
CIGNA (NYSE:CI) last posted its quarterly earnings data on Thursday, February 1st. The health services provider reported $1.94 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.87 by $0.07. CIGNA had a return on equity of 18.84% and a net margin of 5.38%. The firm had revenue of $10.53 billion during the quarter, compared to the consensus estimate of $10.28 billion. During the same period in the prior year, the company earned $1.87 EPS. The firm’s revenue was up 5.9% compared to the same quarter last year.
CI has been the subject of several recent research reports. Jefferies Group increased their price objective on CIGNA from $221.00 to $231.00 and gave the company a “buy” rating in a research note on Friday, November 3rd. Zacks Investment Research upgraded shares of CIGNA from a “hold” rating to a “buy” rating and set a $231.00 price objective for the company in a research report on Friday, December 22nd. Citigroup boosted their price objective on shares of CIGNA from $198.00 to $231.00 and gave the stock a “buy” rating in a research report on Friday, November 3rd. ValuEngine upgraded shares of CIGNA from a “hold” rating to a “buy” rating in a research report on Sunday, December 31st. Finally, Morgan Stanley boosted their price objective on shares of CIGNA from $195.00 to $223.00 and gave the stock an “overweight” rating in a research report on Friday, November 3rd. Three investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $210.12.
CIGNA (NYSE CI) traded up $2.55 during midday trading on Monday, reaching $194.20. The company had a trading volume of 399,215 shares, compared to its average volume of 1,430,091. CIGNA has a 1 year low of $143.85 and a 1 year high of $227.13. The company has a current ratio of 0.37, a quick ratio of 0.39 and a debt-to-equity ratio of 0.38. The firm has a market cap of $47,250.00, a P/E ratio of 20.99, a P/E/G ratio of 1.16 and a beta of 0.44.
In other CIGNA news, Director Donna F. Zarcone sold 5,971 shares of CIGNA stock in a transaction on Tuesday, January 16th. The shares were sold at an average price of $215.43, for a total transaction of $1,286,332.53. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP John M. Murabito sold 6,099 shares of the business’s stock in a transaction on Thursday, January 18th. The shares were sold at an average price of $220.10, for a total transaction of $1,342,389.90. Following the completion of the transaction, the executive vice president now directly owns 68,026 shares of the company’s stock, valued at approximately $14,972,522.60. The disclosure for this sale can be found here. Insiders have sold a total of 64,663 shares of company stock valued at $13,329,903 in the last ninety days. Company insiders own 1.30% of the company’s stock.
Hedge funds have recently made changes to their positions in the company. Financial Gravity Companies Inc. acquired a new position in shares of CIGNA in the 4th quarter valued at $112,000. Saratoga Research & Investment Management acquired a new position in shares of CIGNA in the 3rd quarter valued at $112,000. Stuart Chaussee & Associates Inc. acquired a new position in shares of CIGNA in the 4th quarter valued at $122,000. Cerebellum GP LLC acquired a new position in CIGNA in the 4th quarter worth $127,000. Finally, Horan Capital Advisors LLC. acquired a new position in CIGNA in the 3rd quarter worth $123,000. 87.84% of the stock is owned by institutional investors.
WARNING: This piece was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be accessed at https://www.dispatchtribunal.com/2018/02/22/zacks-analysts-anticipate-cigna-co-ci-to-post-3-39-earnings-per-share.html.
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Get a free copy of the Zacks research report on CIGNA (CI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.